Improving treatment intensification to reduce cardiovascular disease risk: a cluster randomized trial
<p>Abstract</p> <p>Background</p> <p>Blood pressure, lipid, and glycemic control are essential for reducing cardiovascular disease (CVD) risk. Many health care systems have successfully shifted aspects of chronic disease management, including population-based outreach p...
Main Authors: | Selby Joe V, Schmittdiel Julie A, Fireman Bruce, Jaffe Marc, Ransom Laura J, Dyer Wendy, Uratsu Connie S, Reed Mary E, Kerr Eve A, Hsu John |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-07-01
|
Series: | BMC Health Services Research |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1472-6963/12/183 |
Similar Items
-
Patterns and predictors of antihyperglycemic intensification at hospital discharge for type 2 diabetic patients not on home insulin
by: Mohammed S. Abusamaan, et al.
Published: (2020-06-01) -
Virtual Inertia Coordinated Allocation Method Considering Inertia Demand and Wind Turbine Inertia Response Capability
by: Bo Xu, et al.
Published: (2021-08-01) -
Genetic and biochemical aspects of dyslipidaemias in Chinese.
Published: (2001) -
Choosing lipid lowering statin in risk strategy of cardiovascular event prevention
by: A. Ya. Yvleva, et al.
Published: (2007-02-01) -
Study protocol: The Adherence and Intensification of Medications (AIM) study - a cluster randomized controlled effectiveness study
by: Selby Joe, et al.
Published: (2010-10-01)